Company / Inventory
CG Oncology, Inc. Inventory History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$1.6M
FY2025
5-year range
$0 / $1.6M
FY2024-FY2025
Trend
-
vs FY2024
Sector context
#101 of 105
Health Care
What the data says
Among 105 Health Care companies, CG Oncology, Inc. is in the bottom 4% for inventory.
Based on SEC 10-K filings.
$2M in FY2025.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 105This company $1.6M Sector average $885.3M
▼
-99.8% below sector average
Key checks
Key Insights
- Ranks #101 out of 105 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 8.02 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.6M | - |
| FY2024 | $0 | - |
| FY2023 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026